S Munkvad
About
In The Last Decade
S Munkvad
23 papers receiving 292 citations
Peers
Comparison fields: 5 of 48
- Hematology 120
- Cardiology and Cardiovascular Medicine 99
- Pulmonary and Respiratory Medicine 92
- Surgery 79
- Internal Medicine 74
Countries citing papers authored by S Munkvad
This map shows the geographic impact of S Munkvad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Munkvad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Munkvad more than expected).
Fields of papers citing papers by S Munkvad
This network shows the impact of papers produced by S Munkvad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Munkvad. The network helps show where S Munkvad may publish in the future.
Co-authorship network of co-authors of S Munkvad
This figure shows the co-authorship network connecting the top 25 collaborators of S Munkvad. A scholar is included among the top collaborators of S Munkvad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Munkvad. S Munkvad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | [Activated protein C resistance in patients with venous leg ulcer]. | 1 |
| 2 | 27 | |
| 3 | 30 | |
| 4 | 1 | |
| 5 | 13 | |
| 6 | 13 | |
| 7 | The fibrinolysis and coagulation systems in ischaemic heart disease. Risk markers and their relation to metabolic dysfunction of the arterial intima. | 13 |
| 8 | Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways. | 14 |
| 9 | 1 | |
| 10 | 26 | |
| 11 | 8 | |
| 12 | 3 | |
| 13 | 80 | |
| 14 | 2 | |
| 15 | 16 | |
| 16 | 35 | |
| 17 | 1 | |
| 18 | 5 | |
| 19 | 8 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.